Evidence map›Paper›PMID 26646009›Full record

ArticlemBio2015

Helicobacter pylori Resists the Antimicrobial Activity of Calprotectin via Lipid A Modification and Associated Biofilm Formation.

Jennifer A Gaddy, Jana N Radin, Thomas W Cullen, Walter J Chazin, Eric P Skaar, M Stephen Trent, Holly M S Algood

Open access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Molecular Mechanisms of Biofilm Formation inAntibiotics (Basel, Switzerland) · 2024
    Review
  9. Phytochemical Composition, Antioxidant, Anti-Biotech (Basel (Switzerland)) · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. The Effects ofBiomedicines · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jennifer A GaddyVeterans Affairs Tennessee Valley Healthcare Services, Nashville, Tennessee, USA Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.
Jana N RadinDepartment of Medicine, Vanderbilt University, Nashville, Tennessee, USA.
Thomas W CullenInstitute of Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas, USA.
Walter J ChazinDepartment of Biochemistry, Vanderbilt University, Nashville, Tennessee, USA Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, USA.
Eric P SkaarVeterans Affairs Tennessee Valley Healthcare Services, Nashville, Tennessee, USA Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
M Stephen TrentDepartment of Infectious Diseases, University of Georgia, Athens, Georgia, USA.
Holly M S AlgoodVeterans Affairs Tennessee Valley Healthcare Services, Nashville, Tennessee, USA Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA holly.m.algood@vanderbilt.edu.
VA Tennessee Valley Healthcare System · USVanderbilt University · USThe University of Texas at Austin · USUniversity of Georgia · US

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
The role of Th17 cytokines in H.pylori infectionI01BX000915 · VA · VETERANS HEALTH ADMINISTRATION · PI HOLLY Marie Scott ALGOOD · 2011 to 2026
–
Regulation of Helicobacter pylori pili encoded by the cag pathogenicity islandIK2BX001701 · VA · VETERANS HEALTH ADMINISTRATION · PI GADDY, JENNIFER A · 2013 to 2017
–
BLRD VA I01 BX000915BLRD VA IK2 BX001701NIDDK NIH HHS P30 DK058404NIDDK NIH HHS P30DK058404
6 · The paper itself

Abstract

unlabelledHelicobacter pylori is one of several pathogens that persist within the host despite a robust immune response. H. pylori elicits a proinflammatory response from host epithelia, resulting in the recruitment of immune cells which manifests as gastritis. Relatively little is known about how H. pylori survives antimicrobials, including calprotectin (CP), which is present during the inflammatory response. The data presented here suggest that one way H. pylori survives the nutrient sequestration by CP is through alteration of its outer membrane. CP-treated H. pylori demonstrates increased bacterial fitness in response to further coculture with CP. Moreover, CP-treated H. pylori cultures form biofilms and demonstrate decreased cell surface hydrophobicity. In response to CP, the H. pylori Lpx lipid A biosynthetic enzymes are not fully functional. The lipid A molecules observed in H. pylori cultures treated with CP indicate that the LpxF, LpxL, and LpxR enzyme functions are perturbed. Transcriptional analysis of lpxF, lpxL, and lpxR indicates that metal restriction by CP does not control this pathway through transcriptional regulation. Analyses of H. pylori lpx mutants reveal that loss of LpxF and LpxL results in increased fitness, similar to what is observed in the presence of CP; moreover, these mutants have significantly increased biofilm formation and reduced cell surface hydrophobicity. Taken together, these results demonstrate a novel mechanism of H. pylori resistance to the antimicrobial activity of CP via lipid A modification strategies and resulting biofilm formation. IMPORTANCE: Helicobacter pylori evades recognition of the host's immune system by modifying the lipid A component of lipopolysaccharide. These results demonstrate for the first time that the lipid A modification pathway is influenced by the host's nutritional immune response. H. pylori's exposure to the host Mn- and Zn-binding protein calprotectin perturbs the function of 3 enzymes involved in the lipid A modification pathway. Moreover, CP treatment of H. pylori, or mutants with an altered lipid A, exhibit increased bacterial fitness and increased biofilm formation. This suggests that H. pylori modifies its cell surface structure to survive under the stress imposed by the host immune response. These results provide new insights into the molecular mechanisms that influence the biofilm lifestyle and how endotoxin modification, which renders H. pylori resistant to cationic antimicrobial peptides, can be inactivated in response to sequestration of nutrient metals.

Indexed as

AcyltransferasesAnti-Bacterial AgentsBacterial ProteinsBiofilmsCell MembraneDrug Resistance, BacterialHelicobacter pyloriHydrophobic and Hydrophilic InteractionsLeukocyte L1 Antigen ComplexLipid ALipopolysaccharidesPhenotypeAcyltransferasesAnti-Bacterial AgentsBacterial ProteinsLeukocyte L1 Antigen ComplexLipid ALipopolysaccharidesLpxL protein, bacteria

Identifiers

PMID26646009
PMCPMC4669380
OpenAlexW2195139930

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.